Enzymatica’s shares were admitted for trading on Nasdaq First North on June 15, 2015.
The number of shares is 142,823,696. Closing price on Friday, December 28, 2018 was SEK 2.20, corresponding to a market capitalization of approximately SEK 314 million. In 2018, average turnover per trading day was approximately 56,561 shares, equivalent to approximately SEK 195,000.
The Enzymatica share
ISIN code: SE0003943620
Sector: Health care
About Nasdaq First North
First North is an alternative market, operated by the various exchanges within Nasdaq. It does not have the same legal status as a regulated market. Companies on First North are subject to the rules of First North and not the legal requirements for admission to trading on a regulated market. An investment in a company traded on First North is riskier than an investment in a listed company.